Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of levetiracetam sustained-release tablet and preparation method thereof

A technology of sustained-release tablet and sustained-release layer, which is applied in the field of levetiracetam sustained-release tablet and its preparation, and can solve the problems of ineffectiveness and the like

Active Publication Date: 2016-01-20
南京亿华药业有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This extended release tablet does not work well with levetiracetam, which is very water soluble

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of levetiracetam sustained-release tablet and preparation method thereof
  • A kind of levetiracetam sustained-release tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] First, put the raw materials and auxiliary materials at 60°C for 4 hours, pass through an 80-mesh sieve for later use; then, prepare a blank layer: take 200 g of glyceryl behenic acid and 15 g of polyvinylpyrrolidone K3015 g and mix them uniformly in equal increments. Granulation by method, weighing; Preparation of drug-containing sustained-release layer: levetiracetam 500g, glyceryl behenate 150g, polyvinylglycerol 150g, polyvinylpyrrolidone K3020g are mixed with equal increments, dry granulation, Weighing; tableting: add 1% magnesium stearate to the blank layer and the drug-containing layer and mix them evenly, separate them into two hoppers and compress them into 1000 tablets on a double-layer tablet press. Each tablet contains 500mg of levetiracetam.

Embodiment 2

[0033] First, put the raw materials and auxiliary materials at 60°C and dry them for 4 hours, pass through an 80-mesh sieve for later use; then, prepare a blank layer: take 300 g of ethyl cellulose and 15 g of polyvinylpyrrolidone K3015 g and mix them uniformly in equal increments, and wet-process Granules, weighed; preparation of drug-containing sustained-release layer: levetiracetam 500g, ethyl cellulose 200g, polyvinylpyrrolidone K3020g were mixed in equal increments, wet granulated, weighed; tabletting: the blank Add 1% magnesium stearate to the layer and the drug-containing layer and mix evenly, separate the two hoppers and compress it into 1000 tablets on a double-layer tablet press. Each tablet contains 500mg of levetiracetam.

Embodiment 3

[0035] First, put the raw materials and auxiliary materials at 60°C for 4 hours, pass through an 80-mesh sieve for later use; then, prepare a blank layer: take 180 g of hypromellose and 20 g of polyvinylpyrrolidone K3020 g and mix them uniformly in an equal increment method, dry Granulation by method, weighing; preparation of drug-containing sustained-release layer: levetiracetam 500g hypromellose 150g, polyvinylpyrrolidone K30 20g were mixed with the same amount increasing method, dry granulation, weighing; tabletting: the The blank layer and the drug-containing layer are respectively added with 1% magnesium stearate and mixed evenly, separated into two hoppers and compressed into 1000 tablets on a double-layer tablet press. Each tablet contains 500mg of levetiracetam.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a levetiracetam sustained-release tablet and a preparation method thereof. In the present invention, after drying the required raw materials and auxiliary materials of the sustained-release tablet, they are divided into a blank layer (according to the batching ratio of the blank layer, the slow-release material and adhesive are mixed uniformly and sieved) and the slow-release layer ( Take levetiracetam, sustained-release material and adhesive according to the batching ratio of the sustained-release layer, mix them uniformly according to the method of equal increase, and weigh the granules respectively, add lubricant, mix well, and place in a double-layer Tablets are made in the two hoppers of the tablet press.

Description

1. Technical field [0001] The invention relates to levetiracetam sustained-release tablets and a preparation method thereof. 2. Background technology: [0002] Clinically used levetiracetam, due to the nature of the drug itself, is made into ordinary tablets and taken, which will be quickly metabolized in the human body, and sometimes even needs to be taken at night, which has many adverse effects on the therapeutic effect and patients. In order to achieve an effective therapeutic effect, the frequency of taking the drug must be increased. This will cause the shortcomings of many times of taking medicine, large fluctuations in blood drug concentration, and large side effects. In order to improve the curative effect of the drug, reduce the number of times of taking the drug, and ensure the safety of the drug, levetiracetam must be made into a sustained-release tablet. Levetiracetam sustained-release tablets are usually uniform sustained-release tablets made by mixing the ma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/24A61K31/4015
Inventor 杨鹏辉张胜举丁峰张霞陈广宇
Owner 南京亿华药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com